File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

TitleValidation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
Authors
Wang, XWang, XYHodgson, LGeorge, SSargent, DFoster, NGanti, AStinchcombe, TCrawford, JKratzke, RAdjei, AKindler, HVokes, EPang, HMH
KeywordsMalignant mesothelioma
Overall survival
Progression-free survival
Risk factors
Surrogate endpoint
Issue Date2017
PublisherAlphaMed Press, Inc. The Journal's web site is located at http://www.theoncologist.org/
Citation
The Oncologist, 2017, v. 22, p. 189-198 How to Cite?
DOI: http://dx.doi.org/10.1634/theoncologist.2016-0121
Persistent Identifierhttp://hdl.handle.net/10722/262255
ISSN
1083-7159
2021 Impact Factor: 5.837
2020 SCImago Journal Rankings: 2.176
ISI Accession Number ID
WOS:000395663800012

 

DC FieldValueLanguage
dc.contributor.authorWang, X-
dc.contributor.authorWang, XY-
dc.contributor.authorHodgson, L-
dc.contributor.authorGeorge, S-
dc.contributor.authorSargent, D-
dc.contributor.authorFoster, N-
dc.contributor.authorGanti, A-
dc.contributor.authorStinchcombe, T-
dc.contributor.authorCrawford, J-
dc.contributor.authorKratzke, R-
dc.contributor.authorAdjei, A-
dc.contributor.authorKindler, H-
dc.contributor.authorVokes, E-
dc.contributor.authorPang, HMH-
dc.date.accessioned2018-09-28T04:56:07Z-
dc.date.available2018-09-28T04:56:07Z-
dc.date.issued2017-
dc.identifier.citationThe Oncologist, 2017, v. 22, p. 189-198-
dc.identifier.issn1083-7159-
dc.identifier.urihttp://hdl.handle.net/10722/262255-
dc.languageeng-
dc.publisherAlphaMed Press, Inc. The Journal's web site is located at http://www.theoncologist.org/-
dc.relation.ispartofThe Oncologist-
dc.subjectMalignant mesothelioma-
dc.subjectOverall survival-
dc.subjectProgression-free survival-
dc.subjectRisk factors-
dc.subjectSurrogate endpoint-
dc.titleValidation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials-
dc.typeArticle-
dc.identifier.emailPang, HMH: herbpang@hku.hk-
dc.identifier.authorityPang, HMH=rp01857-
dc.identifier.doi10.1634/theoncologist.2016-0121-
dc.identifier.scopuseid_2-s2.0-85014542806-
dc.identifier.hkuros293214-
dc.identifier.volume22-
dc.identifier.spage189-
dc.identifier.epage198-
dc.identifier.isiWOS:000395663800012-
dc.publisher.placeUnited States-
dc.identifier.issnl1083-7159-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats